This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Clinical use

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • like other class I anti-arrhythmic drugs, the use of flecainide is usually limited to patients with structurally normal hearts
  • the main use is the termination of symptomatic acute atrial fibrillation and in the prevention of recurrence of atrial fibrillation

Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page